Enveda secures $311 million in third consecutive megaround to advance discovery and weight-maintenance programs
read at Endpoints ↗DealPositive
Enveda, a biotech startup operating out of Colorado and India, announced a new financing round on September 23, 2026.
The company raised $311 million, marking its third large-scale funding round in as many years.
The capital will be used to advance its discovery platform that mines plant and microbe chemistry and to develop drug candidates aimed at weight maintenance.
The infusion of funds underscores continued investor interest in Enveda's approach and supports ongoing research and development activities.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Enveda raises its third megaround for I&I and weight maintenance drug candidates”
read at Endpoints ↗91 words · retrieved Sep 23
comments(0)
5-min edit window · permanent after that